The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
June 10th 2024
Patients with undiagnosed asthma or COPD who received usual care from their primary providers were more likely to visit the hospital or specialists because of respiratory illness.
Symbicort Now Approved for Young Children
January 28th 2017Officials with AstraZeneca recently announced that the FDA has expanded the indication of its 80/4.5 mcg budesonide and formoterol fumarate dihydrate inhalation aerosol (Symbicort), approving the drug for the treatment of asthma in patients aged 6 to 12 years.
Read More